US Equity
ACAD
— ACADIA PHARMACEUTICALS INC.Acadia Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders, including Parkinson's disease psychosis.
💰 Market cap: $4.35B📍 12830 El Camino Real, Suite 400, SAN DIEGO, CA, 92130 US🏷️ Biotechnology & Medical Research💵 Previous close: $24.84🔢 5,852 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $24.84 |
| 2026-07-23 | $24.83 |
| 2026-07-22 | $24.96 |
| 2026-07-21 | $25.43 |
| 2026-07-20 | $25.09 |
| 2026-07-17 | $25.60 |
| 2026-07-16 | $25.63 |
| 2026-07-15 | $25.92 |
| 2026-07-14 | $25.49 |
| 2026-07-13 | $25.50 |
| 2026-07-10 | $26.22 |
| 2026-07-09 | $26.41 |
| 2026-07-08 | $26.00 |
| 2026-07-07 | $26.20 |
| 2026-07-06 | $25.77 |
| 2026-07-02 | $25.97 |
| 2026-07-01 | $25.20 |
| 2026-06-30 | $25.30 |
| 2026-06-29 | $25.20 |
| 2026-06-26 | $25.32 |
| 2026-06-25 | $23.72 |
| 2026-06-24 | $23.36 |
| 2026-06-23 | $22.60 |
| 2026-06-22 | $22.09 |
| 2026-06-18 | $21.62 |
| 2026-06-17 | $21.60 |
| 2026-06-16 | $20.94 |
| 2026-06-15 | $21.27 |
| 2026-06-12 | $21.09 |
| 2026-06-11 | $21.39 |
| 2026-06-10 | $21.25 |
| 2026-06-09 | $21.84 |
| 2026-06-08 | $21.70 |
| 2026-06-05 | $21.56 |
| 2026-06-04 | $21.72 |
| 2026-06-03 | $21.43 |
| 2026-06-02 | $20.89 |
| 2026-06-01 | $21.52 |
| 2026-05-29 | $21.66 |
| 2026-05-28 | $21.63 |
| 2026-05-27 | $21.19 |
| 2026-05-26 | $21.26 |
| 2026-05-22 | $21.10 |
| 2026-05-21 | $21.32 |
| 2026-05-20 | $20.95 |
| 2026-05-19 | $20.48 |
| 2026-05-18 | $20.69 |
| 2026-05-15 | $21.40 |
| 2026-05-14 | $22.09 |
| 2026-05-13 | $22.18 |
| 2026-05-12 | $21.72 |
| 2026-05-11 | $21.80 |
| 2026-05-08 | $22.40 |
| 2026-05-07 | $22.56 |
| 2026-05-06 | $21.48 |
| 2026-05-05 | $22.35 |
| 2026-05-04 | $22.19 |
| 2026-05-01 | $21.95 |
| 2026-04-30 | $22.45 |
| 2026-04-29 | $22.20 |
| 2026-04-28 | $22.67 |